By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – PrimeraDx said on Wednesday that is has received ISO 13485:2003 certification.

The certification is used to create a standardized quality system for designing and manufacturing medical devices. BSI Group America performed the certification according to ISO 13485:2003 requirements and focused on the Mansfield, Mass.-based molecular diagnostic firm's design, manufacturing, and distribution operations.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.